David Goodrich, PhD

Interim Chair of the Department of Pharmacology and Therapeutics
Professor of Oncology
Member, Molecular Pharmacology and Cancer Therapeutics Graduate Program
Member, Cancer Genetics CCSG (Cancer Center Support Grant) Program
Roswell Park Cancer Institute
Research Interests: 
Understanding molecular mechanisms underlying tumor suppression mediated by the RB1 and TP53 genes
Identifying genes involved in prostate cancer metastasis
Discerning how transcriptionally formed R-loops contribute to cancer initiation and progression